Short-term androgen deprivation and PSA doubling time: their association and relationship to disease progression after radiation therapy for prostate cancer

By Hanlon A.L.   Horwitz E.M.   Hanks G.E.   Pollack A.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 58, Iss. 1, 2004-01 ,pp. : 43-52

Elsevier

Access to resources Recommend Favorite

Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases

By Schick Ulrike   Jorcano Sandra   Nouet Philippe   Rouzaud Michel   Vees Hansjoerg   Zilli Thomas   Ratib Osman   Weber Damien C.   Miralbell Raymond  

Acta Oncologica, Vol. 52, Iss. 8, 2013-11 ,pp. : 1622-1628

Informa Healthcare

Access to resources Recommend Favorite

Immune Modulation by Androgen Deprivation and Radiation Therapy: Implications for Prostate Cancer Immunotherapy

By Kalina Jennifer L.   Neilson David S.   Comber Alexandra P.   Rauw Jennifer M.   Alexander Abraham S.   Vergidis Joanna   Lum Julian J.  

Cancers, Vol. 9, Iss. 2, 2017-01 ,pp. : 13-13

MDPI

Access to resources Recommend Favorite

Treatment for intermediate and high-risk prostate cancer: Controversial issues and the role of hyperthermia

By Maluta Sergio   Dall'oglio Stefano   Nadalini Luisa  

International Journal of Hyperthermia, Vol. 26, Iss. 8, 2010-12 ,pp. : 765-774

Informa Healthcare

Access to resources Recommend Favorite

The high-risk prostate cancer patient

By Hussain M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 3, 2003-05 ,pp. : 211-211

Elsevier

Access to resources Recommend Favorite